Stanford researchers have identified more than 20 mouse lemurs with genetic traits for conditions such as heart disease and eye problems, making the tiny primates potentially useful for understanding diseases in humans.
Targeting backup biological pathways often used by cancers can lead to more efficient drug development and less-toxic therapies. Stanford researchers have developed a new way to identify these pathways.
In a randomized clinical trial conducted by researchers at Stanford and more than 100 other medical centers, psoriatic arthritis patients given an injectable biologic drug for 24 weeks showed substantial improvement compared with patients who received placebo injections.
Inside Stanford Medicineis a twice-monthly newspaper that reports on the accomplishments and activities of the faculty, staff and students in the Stanford Medicine community. To suggest a story or to get more information, contact editor John Sanford at (650) 723-8309 or email@example.com.
You're receiving this newsletter because you registered with us.
Not interested anymore? Unsubscribe here.